Recently, ITGB1 has been characterized to induce EMT in HCC cell lines through ILK-AKT-mTOR signaling cascade, leading to more aggressive and drug-resistant phenotypes in HCC cells (Jiang et al., 2015). This evidence concerns the gene ITGB1 and hepatocellular carcinoma.